Bioblast

1 stories about Bioblast
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”